Small Molecule Libraries Targeted to CBP and Attenuation AfosB Expression
靶向 CBP 和减弱 AfosB 表达的小分子文库
基本信息
- 批准号:8484932
- 负责人:
- 金额:$ 42.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcuteAddictive BehaviorAddressAffinityAmphetaminesAnimalsAreaAttenuatedBackBehavioralBehavioral ModelBindingBiologicalBiological AssayBiological AvailabilityBrainBromodomainCREB-binding proteinCell NucleusCellsChemicalsChronicCocaineComplexComputational TechniqueDatabasesDoseDrug AddictionERG geneEpigenetic ProcessEvaluationEventExposure toFluorescenceFluorescence SpectroscopyGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGoalsHalf-LifeHistone AcetylationHistone H3HistonesHumulusIn VitroIndividualInhibitory Concentration 50InvestigationLabelLeadLearningLibrariesLifeLigand BindingLigandsLinkLuciferasesLysineMeasuresMediatingMemoryMental disordersMethodsMethylationModalityModelingMolecular ModelsNeuronal PlasticityNeuronsNucleus AccumbensOralParentsPatternPenetrationPharmaceutical ChemistryPharmaceutical PreparationsPharmacologyPhasePhosphorylationPreparationPreventionProcessPropertyPsyche structureRNA SplicingRattusReagentRecruitment ActivityRelapseReporterResearchRewardsRodent ModelRoentgen RaysRoleRouteRunningSafetyScreening procedureSeriesSpecificityStagingStimulusStructureSynthesis ChemistrySystemTechniquesTestingTimeTranscriptional ActivationTransferaseTryptophanUbiquitinationVariantaddictionattenuationbasedesigndrug of abusedrug seeking behaviorhigh throughput screeninghuman CREBBP proteinin vivoinhibitor/antagonistinsightlead seriesmolecular modelingnovelnovel therapeuticsprogramspromoterprotein expressionprotein functionresponsescaffoldscale upsmall moleculesmall molecule librariessocialstimulant abusetooltranscription factor
项目摘要
Addiction is a chronic, relapsing psychiatric disorder characterized by compulsive drug seeking
behaviors despite significant physical, mental and social harm to the individuals involved. Progress
has been made in elucidating the underlying neuroadaptions that occur in addiction. These involve,
in part, a subversion, or hijacking of normal neuronal plasticity associated reward, memory and
learning. One of the ways cells respond to external stimuli, including pathological stimuli such as
abused psychostimulants, is by altering their pattern of gene expression and one mechanism for this
is via epigenetic changes leading to altered patterns of gene transcription. Induction ¿FosB is a well
characterized neuroplastic event associated with chronic administration of these drugs.
Exposure to abused psycostimulants, for example cocaine, leads to histone acetylation of gene
promoters, and consequent transcriptional activation, of early response genes, including FosB.
Increase in FosB promoter acetylation has been shown to be dependant on CBP (CREB binding
protein) dependant histone acetyl transferase (HAT) activity. Thus exposure to drugs of abuse such
cocaine and amphetamines have been shown to lead to increase FosB protein expression in cells of
the nucleus accumbens. On chronic treatment, a longer lived truncated splice variant of FosB,
¿FosB, is expressed and this accumulates in neurons as the transition to an addicted state occurs.
¿FosB is present for an extended period of time after drug is withdrawn and it has thus been
implicated as a causative agent in the formation of longer term addictive behaviors and hence
propensity for relapse. The key biological hypothesis to be tested by the proposed research is
that attenuation of CBP activity by a small molecule inhibitor will reduce acetylation of the
FosB gene promoter, which in turn will lower FosB and ¿FosB protein expression.
High throughput screens of chemical libraries at Mount Sinai have identified two series of hit
molecules in a binding assay to CBP bromodomain. Further, these hits have been shown to inhibit
CBP mediated HAT activity in cell based reporter assays. These chemical lead series are amenable
to exploration and elaboration by parallel synthesis techniques to create libraries of CBP inhibitors.
The broad theme of this proposal is to optimize these hits via targeted library synthesis and
medicinal chemistry to provide small molecules which will inhibit ¿FosB induction via
attenuation of CBP HAT activity. These small molecules will function as pharmacological tools to
investigate the underlying neuronal adaptations in transition to the addicted state and may provide a
novel therapeutic modality for the prevention or reversal of addiction.
成瘾是一种慢性、复发性精神障碍,其特征是强迫性寻求毒品。
对涉案个人造成重大身体、精神和社会伤害的行为。进展
已经在阐明成瘾发生的潜在神经适应方面取得了进展。这些措施包括:
在某种程度上,颠覆或劫持正常神经元可塑性与奖赏、记忆和
学习。细胞对外界刺激的反应方式之一,包括病理刺激,如
滥用精神刺激剂,是通过改变其基因表达模式和一种机制来实现的
是通过表观遗传变化导致基因转录模式改变。感应?FosB是一口井
表征了与长期服用这些药物有关的神经整形事件。
暴露在滥用的精神刺激剂中,例如可卡因,会导致基因的组蛋白乙酰化
包括FosB在内的早期反应基因的启动子以及随后的转录激活。
FosB启动子乙酰化的增加已被证明依赖于CBP(CREB结合
蛋白质)依赖组蛋白乙酰转移酶(HAT)活性。因此,接触滥用药物的情况如下
可卡因和苯丙胺被证明能增加FosB蛋白的表达
伏隔核。在慢性治疗方面,FosB的一种寿命更长的截断剪接变体,
FosB在神经元中表达,并随着向成瘾状态的转变而积累。
FosB在停药后存在较长一段时间,因此
作为长期成瘾行为形成的诱因,因此
故态复萌。这项拟议的研究要检验的关键生物学假设是
小分子抑制剂对CBP活性的减弱将减少CBP的乙酰化
FosB基因启动子,进而降低FosB和FosB蛋白的表达。
西奈山化学图书馆的高通量筛查发现了两个系列的热门
与CBP溴域结合的分子。此外,这些命中已被证明抑制
CBP在基于细胞的报告分析中介导HAT活性。这些化学铅系列是可接受的。
通过平行合成技术探索和精制以创建CBP抑制剂的文库。
这项提议的广泛主题是通过有针对性的文库合成和
药物化学提供将抑制FosB诱导的小分子
CBP HAT活性的衰减。这些小分子将作为药理工具发挥作用
研究向成瘾状态转变中潜在的神经元适应,并可能提供
预防或逆转成瘾的新治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Ohlmeyer其他文献
Michael Ohlmeyer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Ohlmeyer', 18)}}的其他基金
Direct Activation of PP2A as a Novel Approach to Group-3 Medulloblastoma Therapy
直接激活 PP2A 作为 3 组髓母细胞瘤治疗的新方法
- 批准号:
10382481 - 财政年份:2022
- 资助金额:
$ 42.19万 - 项目类别:
Small Molecule Libraries Targeted to CBP and Attenuation AfosB Expression
靶向 CBP 和减弱 AfosB 表达的小分子文库
- 批准号:
8507692 - 财政年份:2010
- 资助金额:
$ 42.19万 - 项目类别:
Small Molecule Libraries Targeted to CBP and Attenuation AfosB Expression
靶向 CBP 和减弱 AfosB 表达的小分子文库
- 批准号:
8660675 - 财政年份:2010
- 资助金额:
$ 42.19万 - 项目类别:
Small Molecule Libraries Targeted to CBP and Attenuation AfosB Expression
靶向 CBP 和减弱 AfosB 表达的小分子文库
- 批准号:
7998834 - 财政年份:2010
- 资助金额:
$ 42.19万 - 项目类别:
Small Molecule Libraries Targeted to CBP and Attenuation AfosB Expression
靶向 CBP 和减弱 AfosB 表达的小分子文库
- 批准号:
8119022 - 财政年份:2010
- 资助金额:
$ 42.19万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 42.19万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 42.19万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 42.19万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 42.19万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 42.19万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 42.19万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 42.19万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 42.19万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 42.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 42.19万 - 项目类别:
Operating Grants